iX Biopharma Targets Non-Opioid Pain and U.S. Telehealth Growth With Wafermine Funding and Consumer Spinoff

TIPRANKS07-03 20:22

iX Biopharma Ltd. ( ($SG:42C) ) has issued an announcement. iX Biopharma has outlined a multi-pronged growth strategy centred on Wafermine and its ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment